Table 3.
Laboratory parameters before and one week after completion of the treatment (n = 133)
| Pre treatment | Post treatment | p-Value | |
|---|---|---|---|
| Hemoglobin, g/dl | 9.71±1.4 | 9.16 ±1.5 | < 0.001 |
| Total leukocyte count, x 109/L | 7.36 ±2.17 | 7.37 ± 4.21 | 0.67 |
| Platelet count, x 109/L | 256.06 ± 98.93 | 226.52±94.90 | < 0.001 |
| Total bilirubin, mg/dl | 0.72 ± 0.28 | 0.70±0.25 | 0.015 |
| Alanine aminotransferase, U/L | 43.69±36.33 | 22.63 ± 21.30 | < 0.001 |
| Aspartate aminotransferase, U/L | 39.70 ±27.39 | 25.11±19.41 | < 0.001 |
| Gamma-glutamyltransferase , U/L | 73.53± 69.21 | 42.34±33.49 | < 0.001 |
| Albumin, mg/dl | 3.43±0.47 | 3.60±0.43 | < 0.001 |
| International normalized ratio | 1.12±0.13 | 1.17±0.15 | 0.196 |
p <0.05 was considered statistically significant